Impact News +++ Ambarella surges after report says company exploring strategic options, including sale (SeekingAlpha) +++ AMBARELLA Aktie +15,53%

Gewinn & Umsatz News zur INSULET Aktie

>INSULET Aktienkurs

266.6 EUR +0.3% (Tradegate)

Ask: 268.1 EUR / 120 Stück

Bid: 267.1 EUR / 120 Stück

Tagesumsatz: 44 Stück

Realtime Kurs von 8 bis 22 Uhr!

INSULET Aktie über LYNX handeln

Intraday

1 Jahr

>INSULET Performance

1 Woche: -0,1%

1 Monat: -6,1%

3 Monate: +7,1%

6 Monate: +5,9%

1 Jahr: +39,8%

laufendes Jahr: +5,6%

>INSULET Aktie

Name:

INSULET CORP. DL -,001

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US45784P1012 / A0MQX8

Symbol/ Ticker:

GOV (Frankfurt) / PODD (NASDAQ)

Kürzel:

FRA:GOV, ETR:GOV, GOV:GR, NASDAQ:PODD

Index:

Webseite:

https://www.insulet.com/

Marktkapitalisierung:

18480 Mio. EUR

Umsatz:

1904.75 Mio. EUR

EBITDA:

367.53 Mio. EUR

Gewinn je Aktie:

4.182 EUR

Schulden:

1515.14 Mio. EUR

Liquide Mittel:

1108.22 Mio. EUR

Umsatz-/ Gewinnwachstum:

28.8% / -31.3%

KGV/ KGV lG:

55.05 / 74.63

KUV/ KBV/ PEG:

10.28 / 16.16 / 7.71

Gewinnm./ Eigenkapitalr.:

18.29% / 37.92%

Dividende je Aktie:

Dividendenrendite/ -schätzung:

- / -

Insiderhandel:

3 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 1.235.337 USD.

Suchwörter:

INSULET

Letzte Datenerhebung:

24.06.25

>INSULET Eigentümer

Aktien: 70.37 Mio. St.

f.h. Aktien: 70.06 Mio. St.

Insider Eigner: 0.29%

Instit. Eigner: 102.63%

Leerverk. Aktien: 2.71%

>INSULET Peer Group

BEONE ADR

BRUKER

EXELIXIS

IMMUNIC

IOVANCE

LIQUIDIA

TRANSMEDICS

TWIST BIOSCIENCE

VANDA

VAXCYTE

>INSULET Chart & Kurs - NASDAQ

>INSULET Gewinn & Umsatz News

09.05.25 - 00:36	Insulet Posts Mixed Q1 Results With Revenue Growth And Lower Earnings (AFX)
	WASHINGTON (dpa-AFX) - Insulet Corporation (PODD), a medical device company, on Thursday posted its first quarter results for 2025. With a net income of $35.4 million for the first quarter of 2025......

28.04.25 - 14:48	Heres What to Expect From Insulets Next Earnings Report (Barchart)
	Insulet is set to release its first-quarter results next month, and analysts expect a double-digit earnings growth....

20.03.25 - 03:24	Insulet′s RADIANT Trial Results Highlight Significant Glycemic Benefits From Omnipod 5 Transition (AFX)
	WASHINGTON (dpa-AFX) - The RADIANT trial conducted by Insulet Corp. (PODD) highlighted significant glycemic improvements with the use of the Omnipod 5 Automated Insulin Delivery System. These impr......

25.02.25 - 13:48	Insulet Stock Outlook: Is Wall Street Bullish or Bearish? (Barchart)
	Insulet has outperformed the broader market over the past year, and analysts are highly optimistic about the stock's prospects....

20.02.25 - 22:36	Insulet Corp. Profit Retreats In Q4 (AFX)
	WASHINGTON (dpa-AFX) - Insulet Corp. (PODD) announced earnings for fourth quarter that decreased from the same period last yearThe company's bottom line came in at $100.7 million, or $1.39 per sha......

27.01.25 - 14:48	Earnings Preview: What to Expect From Insulets Report (Barchart)
	Insulet is scheduled to release its fiscal fourth-quarter earnings next month, and analysts project a double-digit profit decline....

09.08.24 - 02:15	Insulet inventory pressures cloud annual revenue forecast raise (Reuters EN)
	Insulet inventory pressures cloud annual revenue forecast raise...

08.08.24 - 23:18	Insulet Corp. Q2 Profit Increases, But Misses Estimates (AFX)
	WASHINGTON (dpa-AFX) - Insulet Corp. (PODD) announced earnings for its second quarter that increased from the same period last year but missed the Street estimates.The company's earnings totaled $......

26.07.24 - 17:08	Insulet expects higher-than-expected revenue amid diabetes market trend concerns (Reuters EN)
	Insulet expects higher-than-expected revenue amid diabetes market trend concerns...

26.07.24 - 13:27	Insulet expects to beat revenue estimates on strong insulin pump demand (Reuters EN)
	Insulet expects to beat revenue estimates on strong insulin pump demand...

26.07.24 - 13:01	Insulet Preliminary Q2 Revenue Rises; Stock Up In Pre-Market (AFX)
	WASHINGTON (dpa-AFX) - Insulet Corp. (PODD), a tubeless insulin pump technology with its Omnipod brand of products, on Friday registered a rise in preliminary revenue for the second-quarter to $48......

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Was man zu lang bedenkt, das wird bedenklich. - Sprichwort

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram